Cardiovascular risk factors after bariatric surgery: Do patients gain more than expected from their substantial weight loss?

European Journal of Internal Medicine

Volumn 18, Issue 1, 2007, Pages 39-43

  Jazet, I M ^a   de Groot, G H ^b   Tuijnebreyer, W E ^b   Fogteloo, A J ^a   Vandenbroucke, J P ^a   Meinders, A E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RED CROSS HOSPITAL   (Netherlands)

Author keywords

Bariatric surgery; Cardiovascular risk factors; HOMA ; HOMA IR; Obesity; Weight loss

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HOMOCYSTEINE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BARIATRIC SURGERY; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; EXPECTATION; FEMALE; GASTRIC BANDING; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MORBID OBESITY; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

EID: 33846052178     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2006.07.024     Document Type: Article

References (21)

1. Manson J.E., Colditz G.A., Stampfer M.J., Willett W.C., Rosner B., Monson R.R., et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 322 13 (1990) 882-889
2. Hubert H.B., Feinleib M., McNamara P.M., and Castelli W.P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67 5 (1983) 968-977
3. Pi-Sunyer F.X. Medical hazards of obesity. Ann Intern Med 119 7 Pt 2 (1993) 655-660
4. Field A.E., Coakley E.H., Must A., Spadano J.L., Laird N., Dietz W.H., et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161 13 (2001) 1581-1586
5. Rosito G.A., D'Agostino R.B., Massaro J., Lipinska I., Mittleman M.A., Sutherland P., et al. Association between obesity and a prothrombotic state: the Framingham Offspring Study. Thromb Haemost 91 4 (2004) 683-689
6. Case C.C., Jones P.H., Nelson K., O'Brian S.E., and Ballantyne C.M. Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab 4 6 (2002) 407-414
7. Anderson J.W., Brinkman-Kaplan V.L., Lee H., and Wood C.L. Relationship of weight loss to cardiovascular risk factors in morbidly obese individuals. J Am Coll Nutr 13 3 (1994) 256-261
8. Mertens I.L., and Van Gaal L.F. Overweight, obesity, and blood pressure: the effects of modest weight reduction. Obes Res 8 3 (2000) 270-278
9. Greenway S.E., Greenway III F.L., and Klein S. Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg 137 10 (2002) 1109-1117
10. Luyckx F.H., Scheen A.J., Desaive C., Dewe W., Gielen J.E., and Lefebvre P.J. Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diabetes Metab 24 4 (1998) 355-361
11. Muscelli E., Mingrone G., Camastra S., Manco M., Pereira J.A., Pareja J.C., et al. Differential effect of weight loss on insulin resistance in surgically treated obese patients. Am J Med 118 1 (2005) 51-57
12. Andersson B.L., Bjorntorp P., and Seidell J.C. Measuring Obesity-Classification and description of anthropometric data. Report on a WHO consultation on epidemiology of obesity. Copenhagen. Nutrition unit, WHO regional office for Europe; EUR/ICP/NUT vol. 125 (1988) 1-22
13. Levy J.C., Matthews D.R., and Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21 12 (1998) 2191-2192
14. Camastra S., Manco M., Mari A., Baldi S., Gastaldelli A., Greco A.V., et al. Beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss. Diabetes 54 8 (2005) 2382-2389
15. Machann J., Haring H., Schick F., and Stumvoll M. Intramyocellular lipids and insulin resistance. Diabetes Obes Metab 6 4 (2004) 239-248
16. Splaver A., Lamas G.A., and Hennekens C.H. Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials. Am Heart J 148 1 (2004) 34-40
17. Lewington S., Clarke R., Qizilbash N., Peto R., and Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 9349 (2002) 1903-1913
18. Grundy S.M., Cleeman J.I., Merz C.N., Brewer Jr. H.B., Clark L.T., Hunninghake D.B., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 2 (2004) 227-239
19. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285 19 (2001) 2486-2497
20. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 4 (2001) 683-689
21. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 21 (2002) 2709-2716